A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Polatuzumab Vedotin in Combination With Rituximab and CHP (R-CHP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients With Diffuse Large B-Cell Lymphoma
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Polatuzumab Vedotin in Combination With Rituximab and CHP (R-CHP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients With Diffuse Large B-Cell Lymphoma
This Phase III, randomized, double-blind, placebo-controlled study will compare the efficacy, safety, and pharmacokinetics of polatuzumab vedotin plus R-CHP versus R-CHOP in participants with previously untreated diffuse large B-cell lymphoma (DLBCL).
Inclusion Criteria:
Exclusion Criteria:
Fort Myers, Florida 33901-8101, United States
Chapel Hill, North Carolina 27514-4221, United States
Charlotte, North Carolina 28204, United States
Morgantown, West Virginia 26505, United States
Woodville South, South Australia 5011, Australia
Mont-godinne, 5530, Belgium
Tianjin, 300020, China
Wuhan, 430022, China
Bergamo, Abruzzo 24127, Italy
Brescia, Abruzzo 25123, Italy
Rome, Abruzzo DUMMY_VALUE, Italy
Reggio Emilia, Emilia-Romagna DUMMY_VALUE, Italy
Turin, Piedmont 10126, Italy
Hokkaido, 060-8648, Japan
Isehara-shi, 259-1193, Japan
Chorzów, 41-500, Poland
Lzmir, 35100, Turkey (Türkiye)
Cherkassy, Chernihiv Governorate DUMMY_VALUE, Ukraine
Lviv, Chernihiv Governorate 79007, Ukraine
Cambridge, CB2 0QQ, United Kingdom
Leicester, LE1 5WW, United Kingdom